Marco Sbracia

ORCID: 0000-0002-0182-8980 · 24 papers in corpus
article 2024
ENDOMETRIOSIS IN IVF: THE TREATMENT WITH DEGARELIX BEFORE IVF ATTEMPT IMPROVES PATIENT' S REPRODUCTIVE OUTCOME
·doi:10.1016/j.fertnstert.2024.07.560
article 2018
A controlled trial on uterine adenomyosis treatment comparing aromatase inhibitor plus gnrh analogue versus dienogest in women undergoing IVF
·doi:10.1016/j.fertnstert.2018.07.252
article 2017
PIF expression in endometriosis: Its possible role in inducing ectopic endometrium immune-privilege
·doi:10.1016/j.jri.2017.07.012
other 2017
PreImplantation Factor in endometriosis: A potential role in inducing immune privilege for ectopic endometrium
PloS one ·doi:10.1371/journal.pone.0184399

Endometriosis is a chronic inflammatory condition characterised by the growth of endometrial epithelial and stromal cells outside the uterine cavity. In addition to Sampson's theory of retrograde menstruation, endometriosis pathogenesis is …

article 2015
Fas and Fas-Ligand in Eutopic and Ectopic Endometrium of Women With Endometriosis: The Possible Immune Privilege of Ectopic Endometrium
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1177/1933719115594019

The Fas/Fas-Ligand system is an important mediator of apoptosis. We analyzed their expression in tissue specimens obtained from 33 women with severe endometriosis and 18 women without endometriosis. Immunostaining for Fas-Ligand in the euto…

article 2015
Use of depot GNRH antagonist (Degarelix) in the treatment of endometriomas (ovarian endometriosis) before IVF: a controlled trial
·doi:10.1016/j.fertnstert.2015.07.491
article 2013
Session 06: Endometriosis
·doi:10.1093/humrep/det161
article 2012
Use of depot GnRH antagonist (degarelix) in the treatment of endometriosis recurrence. A controlled trial
·doi:10.1016/j.fertnstert.2012.07.242
other 2011
Expression of oct-4 and c-kit antigens in endometriosis
Fertility and sterility ·doi:10.1016/j.fertnstert.2010.10.029

The objective of this study was to test the expression of the oct-4 and c-kit, both markers of stem cells, in the ectopic endometrial tissue of endometriotic lesions of women with severe endometriosis. Our findings show that ectopic epithel…

article 2011
VEGF-Receptor2 and c-KIT expression in epithelial cells of ectopic endometrium of endometriosis implants. Do they identify endometriosis stem cells?
·doi:10.1016/j.fertnstert.2011.07.527
article 2010
Aromatase inhibitor plus GnRH analog in the treatment of relapse of endometriosis in patients not responding to other therapy: a controlled trial
·doi:10.1016/j.fertnstert.2010.07.152
article 2007
Stem cell antigens in ectopic epithelial cells of endometriotic lesions: is endometriosis a disease originated from stem cells?
·doi:10.1016/j.fertnstert.2007.07.209
article 2005
Add-Back Therapy in the Treatment of Endometriosis Associated Pain
·doi:10.1016/j.fertnstert.2005.07.471
article 2004
Add-back therapy in the treatment of endometriosis-associated pain
·doi:10.1016/s1074-3804(04)80273-1
article 2004
Add-back therapy in the treatment of endometriosis-associated pain
Fertility and sterility ·doi:10.1016/j.fertnstert.2004.03.062

ObjectiveTo determine the efficacy of GnRH analogue plus add-back therapy compared with GnRH analogue alone and estroprogestin in patients with relapse of endometriosis-associated pain.DesignRandomized, controlled study.SettingUniversity ho…

article 2002
Anti-angiogenesis treatment with thalidomide in endometriosis: A pilot study
·doi:10.1016/s0015-0282(02)03609-9
article 2002
Is the ectopic endometrium an immuno-privileged tissue? Expression of FAS-receptor/FAS-ligand and bcl2 in endometriotic lesions
·doi:10.1016/s0015-0282(01)03056-4
article 2000
Eutopic and Ectopic Human Endometrium Expresses Cannabinoid Receptors and Produces their Endogenous Ligand
·doi:10.1016/s0015-0282(00)00785-8
article 2000
Is local anesthesia an affordable alternative to general anesthesia for minilaparoscopy?
·doi:10.1016/s1074-3804(00)80019-5

Study objectiveTo determine if minilaparoscopy under local anesthesia is at least as reliable and affordable as that performed under general anesthesia.DesignProspective, randomized study (Canadian Task Force classification I).SettingUniver…

article 1997
52nd Annual Meeting of the American Society for Reproductive Medicine, Boston, Massachusetts, 2-6 November 1996: differential expression ofIGF-I and IGF-II in entopic and ectopic endometria of women with endometriosis and in women without endometriosis

Problem: Factors regulating the development, growth, and differentiation of endometrial cells of endometriotic lesions are poorly understood. To investigate the paracrine-autocrine regulation of ectopic endometrial cell growth, the expressi…

article 1997
Differential Expression of IGF‐I and IGF‐II in Eutopic and Ectopic Endometria of Women With Endometriosis and in Women Without Endometriosis
American journal of reproductive immunology (New York, N.Y. : 1989) ·doi:10.1111/j.1600-0897.1997.tb00238.x

PROBLEM: Factors regulating the development, growth, and differentiation of endometrial cells of endometriotic lesions are poorly understood. To investigate the paracrine-autocrine regulation of ectopic endometrial cell growth, the expressi…

article 1997
Expression of Growth Hormone and of Its Receptor in Human Endometrium During the Menstrual Cycle and in Ectopic Endometrium of Women With Endometriosis
·doi:10.1016/s0015-0282(97)85094-7
article 1997
P-195 Expression of growth hormone and of its receptor in human endometrium during the menstrual cycle and in ectopic endometrium of women with endometriosis
·doi:10.1016/s0015-0282(97)91009-8
article 1997
P-299 Fas and Bcl-2 expression and association with apoptotic cells in eutopic and ectopic endometrium in women with endometriosis
·doi:10.1016/s0015-0282(97)91113-4